Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01696045
Title Phase 2 Study of Ipilimumab in Children and Adolescents (12 to <18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: child
Covered Countries USA | GBR | FRA | ESP | DNK | DEU | BEL

Facility Status City State Zip Country Details
Phoenix Children'S Hospital Phoenix Arizona 85016 United States Details
Childrens Hospital Of La Los Angeles California 90027 United States Details
Children'S Hospital Of Orange County Orange California 92868 United States Details
Children'S Hospital Colorado Aurora Colorado 80045 United States Details
H. Lee Moffitt Cancer Center & Research Institute Tampa Florida 33612 United States Details
James Whitcomb Riley Hospital For Children Indianapolis Indiana 46202 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University Of Pittsburgh Medical Center Cancer Center Pittsburgh Pennsylvania 15232 United States Details
St. Jude Children'S Research Hospital Memphis Tennessee 38105 United States Details
The University Of Texas Md Anderson Cancer Center Houston Texas 77030 United States Details
Primary Children'S Medical Center Salt Lake City Utah 84113 United States Details
University Of Utah Salt Lake City Utah 84113 United States Details
Local Institution Gent 9000 Belgium Details
Local Institution Copenhagen 2100 Denmark Details
Local Institution Lyon 69008 France Details
Local Institution Marseille Cedex 5 13385 France Details
Local Institution Nantes Cedex 1 44093 France Details
Local Institution Villejuif Cedex 94805 France Details
Local Institution Dortmund 44137 Germany Details
Local Institution Erlangen 91054 Germany Details
Local Institution Hamburg 20246 Germany Details
Local Institution M?nster 48149 Germany Details
Local Institution Munster 48149 Germany Details
Local Institution Mexico D.F 02990 Mexico Details
Local Institution Df Distrito Federal 06720 Mexico Details
Local Institution Leon, Guanajato Guanajuato 37000 Mexico Details
Local Institution Esplugues de Llobregat- Barcelona 08950 Spain Details
Local Institution Bristol Avon BS2 8BJ United Kingdom Details
Local Institution Newcastle Northumberland NE1 4LP United Kingdom Details
Local Institution Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field